Thank you for your interest in registering to the event
18. September 2019, 19:00 to 21:00
Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel
Ridgeline Therapeutics is Versant’s newest discovery engine aimed at translating new opportunities from academics into industry quality therapeutic candidates. Based in Basel, this central European location allows for privileged access to both strong academic research as well as large pharmaceutical partners. Alex Mayweg will provide a deeper look into Ridgeline’s approach on company creation, drug discovery and portfolio successes. Participants will also learn about Ridgeline’s collaborations with academics and pharma companies.
When: 18.09.2019, 19:00 - 21:00
Where: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel
Dr. Alex Mayweg, President of Ridgeline Therapeutics, Partner at Versant Ventures
Participation to the event is free of charge; however, your registration by 16th September 2019 is kindly required.
* Required fields
Please fill in all required fields.
Please provide the email address to which we should send the confirmation email:
Lea SteineggerProject Manager Events & MarketingTel.: +41 61 295 50 14E-Mail: email@example.com